Physician profile
Matthew Hasford
NPI 1407848195
$2,987.28
in general payments reported to CMS, 2019-2025
11 companies · $953 in 2025
The $953 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $150 · 2021: $806 · 2022: $709 · 2023: $169 · 2024: $79.89 · 2025: $953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $635 · Travel and Lodging: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $635.36 |
| Travel and Lodging | $565.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,552.31 | 2020-2024 | Titan |
| Procept Biorobotics Corporation | $830.89 | 2025 | |
| Teleflex LLC | $147.09 | 2021-2023 | Urolift |
| Astellas Pharma US INC | $144.79 | 2019-2021 | |
| Janssen Biotech, INC. | $135.59 | 2021-2025 | Rybrevant, Carvykti |
| Boston Scientific Corporation | $55.31 | 2021-2024 | Rezum Generator |
| Antares Pharma, INC. | $50.00 | 2022 | |
| Blue Earth Diagnostics | $25.28 | 2024 | |
| Rochester Medical Corporation | $19.25 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $14.86 | 2021 | |
| Axonics, INC. | $11.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Hasford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.